Thursday, November 13, 2008

Merck, Schering-Plough Avert Vytorin ‘Disaster’ at Heart Meeting

An absence of bad news about the companies' jointly marketed cholesterol drugs at a big heart meeting was enough to count as good news.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)